Onco-Innovations lands $3.5M grant for AI cancer platform
What's the deal? Onco-InnovationsDealroom has a profile for this one. Try Dealroom →, together with Redwood AI CorpDealroom has a profile for this one. Try Dealroom → and academic partners, has won a $3.5 million grant to build SynoGraphDealroom has a profile for this one. Try Dealroom →, an AI-driven oncology platform. The award comes from the Digital Health Innovation Fund, managed by the Terry Fox Research InstituteDealroom has a profile for this one. Try Dealroom →.
What's the endgame? SynoGraph aims to predict clinical outcomes using AI, drawing on proprietary data integration and physicochemical modeling from Redwood AI. The platform will incorporate federated learning and causal AI to sharpen predictions while protecting patient privacy.
Who's involved? The Michael Smith Genome Sciences CentreDealroom has a profile for this one. Try Dealroom → and the Centre de recherche du CHU de Québec-Université LavalDealroom has a profile for this one. Try Dealroom → will supply data for the project. Redwood AI's technology sits at the core, expanding the platform's predictive engine.
Why it stands out: At $3.5 million, the grant ranks in the 90th percentile among 711 comparable grant rounds for the sector and region. That places it near the top of funding awards of its kind.
The signal: The partnership underscores Canada's push to pair AI expertise with multimodal medical data. As grant funders back federated learning and causal AI, cancer research is leaning on privacy-preserving tools to move toward clinical prediction and new treatment strategies.
Read more: webdisclosure.com
Image credit: Onco-Innovations
